SCHEMBL3718131

SCHEMBL3718131

Clc1cccc(I)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31489324 1.00 — —
SCHEMBL3295028 0.78 — —
SCHEMBL58195 0.78 — —
Water SCHEMBL9078960 0.76 — —
Hydrochloric Acid SCHEMBL28806784 0.76 — —
Hydrogen Peroxide SCHEMBL15167446 0.73 TSHR (0.52) —
SCHEMBL1071454 0.71 CYP3A4 (0.50) —
SCHEMBL30492599 0.71 CYP3A4 (0.50) —
SCHEMBL7052424 0.67 — —
SCHEMBL18312065 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113024548-B Process for preparing 2-amino-9H-pyridine [2,3-b ] indole 苏州百灵威超精细材料有限公司 2022-04-22 — — CN claimed
CN-113024548-A Process for preparing 2-amino-9H-pyridine [2,3-b ] indole 苏州百灵威超精细材料有限公司 2021-06-25 — — CN claimed
CN-102321081-B Preparation method of substituted enaminocarbonyl compound used as insecticide and intermediate BAYER CROPSCIENCE AG 2015-05-20 — — CN claimed
US-20260035362-A1 GLP-1R AGONISTS AND USES THEREOF QILU REGOR THERAPEUTICS INC (CN) 2026-02-05 — — US disclosed
EP-4685143-A1 DOUBLE REGULATOR FOR MGLUR5 AND HDAC6 AND USE THEREOF Vivozon,Inc. (KR) 2026-01-28 — — EP disclosed
US-12528784-B2 Alkynyl-(heteroaryl)-carboxamide HCN1 inhibitors HOFFMANN-LA ROCHE INC. (US) 2026-01-20 — — US disclosed
US-12365670-B2 GLP-IR agonists and uses thereof QILU REGOR THERAPEUTICS INC. (CN) 2025-07-22 — — US disclosed
EP-4562015-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME Cedilla Therapeutics, Inc. (US) 2025-06-04 — — EP disclosed
EP-4559915-A1 PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS Novartis AG (CH) 2025-05-28 — — EP disclosed
US-12312353-B2 Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents NOVARTIS AG (CH) 2025-05-27 — — US disclosed
WO-2025076285-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME DELPHIA THERAPEUTICS, INC. (US) 2025-04-10 — — WO disclosed
WO-2007137954-A1 ARYL-4-ETHYNYL-ISOXAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-12-06 — — WO disclosed
EP-1006135-B1 Conjugated N-fluoropyridinium salt-containing polymer and use of the same DAIKIN IND LTD (JP) 2003-02-12 — — EP disclosed
CN-1083435-C Polymer containing conjugated N-fluoropyridinium salt and use thereof DAIKIN IND LTD (JP) 2002-04-24 — — CN disclosed
EP-0787719-B1 CONJUGATED N-FLUOROPYRIDINIUM SALT POLYMER AND USE THEREOF DAIKIN IND LTD (JP) 2001-08-16 — — EP disclosed
CN-1277193-A Polymer containing conjugate N-fluoro pyridinium salt and its use DAIKIN IND LTD (JP) 2000-12-20 — — CN disclosed
EP-1006135-A1 Conjugated N-fluoropyridinium salt-containing polymer and use of the same DAIKIN INDUSTRIES, LIMITED (JP) 2000-06-07 — — EP disclosed
US-5736274-A ANODE ACTIVE MATERIAL AND SOLID ELECTROLYTE FOR BATTERIES; HIGH ELECTROMOTIVE FORCE; HIGH ENERGY DENSITY; POLLUTION CONTROL; FLUORINATING AGENTS; LOW INTERNAL RESISTANCE IN CHARGING AND DISCHARGING DAIKIN INDUSTRIES, LTD. (JP) 1998-04-07 — — US disclosed
CN-1161691-A Polymer containing conjugated N-fluoropyridinium salt and use thereof DAIKIN IND LTD (JP) 1997-10-08 — — CN disclosed
EP-0787719-A1 CONJUGATED N-FLUOROPYRIDINIUM SALT POLYMER AND USE THEREOF DAIKIN INDUSTRIES, LTD. (JP) 1997-08-06 — — EP disclosed
Send feedback